InsidersTradesSigma
Lineage, Inc. Stock: price and insider trades · United States · SEC (Form 4)
Track the Lineage, Inc. stock price and the full directors' dealings record of the company, a listed equity based in United States. Shares are listed on US US, under the supervision of SEC (Form 4). Market capitalisation: €1.9bn. The latest transaction was filed on 11 June 2026 (Attribution). Among the most active insiders: Fleming Abigail S. All data is openly available.
73
Insider Decl.
n/a
Thresholds
€10m
17 ops.
Buy Volume
n/a
n/a
Sell Volume
44Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 26,018 of 28,169 companies
19.1
score / 100
Value24
Quality15
FCF yld-4.0%
Earn yld-5.1%
EV/EBITDA·
ROE-40%
Gross mgn·
Net mgn-2.4%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 11 June 2026
Declarations73 total
4,490 sharesCommon StockSEC:0001628280-26-042562:0
4,490 sharesCommon StockSEC:0001684665-26-000005:0
205 shares@ US$35.550.0004% mcap32.9% of flowCommon StockSEC:0001820887-26-000006:0
2,137 shares@ US$32.7633.2% of flowCommon StockSEC:0001490473-26-000004:1
13,118 shares0Common StockSEC:0001490473-26-000004:0
1,220 shares0Common StockSEC:0002094217-26-000004:0
1,516 shares@ US$32.76100.0% of flowCommon StockSEC:0002094217-26-000004:1
12,203 shares0Common StockSEC:0001820887-26-000004:0
276 shares@ US$32.7629.1% of flowCommon StockSEC:0001820887-26-000004:1
68,334 shares0Common StockSEC:0001748303-26-000004:0
8,422 shares@ US$32.76100.0% of flowCommon StockSEC:0001748303-26-000004:1
676 shares@ US$32.76100.0% of flowCommon StockSEC:0002018508-26-000004:0
20,745 shares0Common StockSEC:0002019216-26-000004:0
13,300 shares@ US$37.496213.1% of flowCommon StockSEC:0002021239-26-000004:0
Canonical exit: 10 Jun 2026 (T+90)
11,222 shares@ US$39.0542Common StockSEC:0002021239-26-000002:0
Canonical exit: 7 Jun 2026 (T+90)
616 shares0Common StockSEC:0002094217-26-000002:0
3,603 shares0Common StockSEC:0002019216-26-000002:0
4,258 shares0Common StockSEC:0002018599-26-000002:0
3,767 shares0Common StockSEC:0002018544-26-000002:0
5,405 shares0Common StockSEC:0002018532-26-000002:0
3,735 shares0Common StockSEC:0002018508-26-000002:0
1,049 shares0Common StockSEC:0001820887-26-000002:0
13,756 shares0Common StockSEC:0001748303-26-000002:0
3,603 shares0Common StockSEC:0001490473-26-000002:0
156,561.95 sharesCommon StockSEC:0001539671-25-000006:0
25 of 73 declarations
About Lineage, Inc.
Lineage, Inc. is a NASDAQ-listed company that specializes in developing innovative solutions for the biotechnology industry. It focuses on research and development of products that enhance health and well-being.